The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells

Abstract Background Human cells can synthesize methionine from homocysteine and folate-coupled methyl groups via the B12-dependent enzyme methionine synthase (MTR). Yet, it has been known for decades that cancer cells fail to grow when methionine is replaced by homocysteine, a phenomenon known as me...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed M. A. El Husseiny, Roland Nilsson
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Cancer & Metabolism
Subjects:
Online Access:https://doi.org/10.1186/s40170-025-00405-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334464445939712
author Mohamed M. A. El Husseiny
Roland Nilsson
author_facet Mohamed M. A. El Husseiny
Roland Nilsson
author_sort Mohamed M. A. El Husseiny
collection DOAJ
description Abstract Background Human cells can synthesize methionine from homocysteine and folate-coupled methyl groups via the B12-dependent enzyme methionine synthase (MTR). Yet, it has been known for decades that cancer cells fail to grow when methionine is replaced by homocysteine, a phenomenon known as methionine dependence. The underlying mechanism remains unknown. Methods Cancer cell lines were cultured with homocysteine in place of methionine, and growth responses were measured. Revertant cells capable of growing in homocysteine were generated through long-term culture with high B12 and analyzed using single-cell RNA-seq. Metabolite uptake/release was measured using isotope dilution and MTR activity was assessed using metabolic flux analysis (MFA). Functional rescue experiments were performed by overexpressing the B12-independent methionine synthase enzyme. Results We report evidence that methionine dependence is caused by low MTR activity secondary to a B12 deficiency. High levels of the B12 cofactor were required to revert methionine-dependent cancer cells to grow on homocysteine. The adapted “revertant” cells display gene expression signatures consistent with reduced invasion and metastasis. Metabolic flux analysis indicated that methionine-dependent cells do not fully activate MTR when cultured in homocysteine. High concentrations of homocysteine partially rescued growth of methionine-dependent cells. Expression of a B12-independent methionine synthase enzyme in cancer cells restored growth on homocysteine and normalized the SAM:SAH ratio, while overexpression of the B12-dependent human enzyme had no effect. Conclusion Methionine dependence in cancer can be driven by low MTR activity secondary to B12 deficiency, at least in the cell lines studied. This mechanistic insight resolves a long-standing question in cancer metabolism and may open new avenues for exploiting the phenomenon for cancer therapy.
format Article
id doaj-art-6e7fa6e2e8884dd8a0e5b99a935c82da
institution Kabale University
issn 2049-3002
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Cancer & Metabolism
spelling doaj-art-6e7fa6e2e8884dd8a0e5b99a935c82da2025-08-20T03:45:34ZengBMCCancer & Metabolism2049-30022025-07-0113111510.1186/s40170-025-00405-2The role of B12 deficiency and methionine synthase in methionine-dependent cancer cellsMohamed M. A. El Husseiny0Roland Nilsson1Cardiovascular Medicine Unit, Department of Medicine (Solna)Cardiovascular Medicine Unit, Department of Medicine (Solna)Abstract Background Human cells can synthesize methionine from homocysteine and folate-coupled methyl groups via the B12-dependent enzyme methionine synthase (MTR). Yet, it has been known for decades that cancer cells fail to grow when methionine is replaced by homocysteine, a phenomenon known as methionine dependence. The underlying mechanism remains unknown. Methods Cancer cell lines were cultured with homocysteine in place of methionine, and growth responses were measured. Revertant cells capable of growing in homocysteine were generated through long-term culture with high B12 and analyzed using single-cell RNA-seq. Metabolite uptake/release was measured using isotope dilution and MTR activity was assessed using metabolic flux analysis (MFA). Functional rescue experiments were performed by overexpressing the B12-independent methionine synthase enzyme. Results We report evidence that methionine dependence is caused by low MTR activity secondary to a B12 deficiency. High levels of the B12 cofactor were required to revert methionine-dependent cancer cells to grow on homocysteine. The adapted “revertant” cells display gene expression signatures consistent with reduced invasion and metastasis. Metabolic flux analysis indicated that methionine-dependent cells do not fully activate MTR when cultured in homocysteine. High concentrations of homocysteine partially rescued growth of methionine-dependent cells. Expression of a B12-independent methionine synthase enzyme in cancer cells restored growth on homocysteine and normalized the SAM:SAH ratio, while overexpression of the B12-dependent human enzyme had no effect. Conclusion Methionine dependence in cancer can be driven by low MTR activity secondary to B12 deficiency, at least in the cell lines studied. This mechanistic insight resolves a long-standing question in cancer metabolism and may open new avenues for exploiting the phenomenon for cancer therapy.https://doi.org/10.1186/s40170-025-00405-2One-carbon metabolismCobalaminMethylationCancer nutrition
spellingShingle Mohamed M. A. El Husseiny
Roland Nilsson
The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
Cancer & Metabolism
One-carbon metabolism
Cobalamin
Methylation
Cancer nutrition
title The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
title_full The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
title_fullStr The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
title_full_unstemmed The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
title_short The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells
title_sort role of b12 deficiency and methionine synthase in methionine dependent cancer cells
topic One-carbon metabolism
Cobalamin
Methylation
Cancer nutrition
url https://doi.org/10.1186/s40170-025-00405-2
work_keys_str_mv AT mohamedmaelhusseiny theroleofb12deficiencyandmethioninesynthaseinmethioninedependentcancercells
AT rolandnilsson theroleofb12deficiencyandmethioninesynthaseinmethioninedependentcancercells
AT mohamedmaelhusseiny roleofb12deficiencyandmethioninesynthaseinmethioninedependentcancercells
AT rolandnilsson roleofb12deficiencyandmethioninesynthaseinmethioninedependentcancercells